Claritin® Rapid Dissolve 10 mg: Potential contamination
Brand(s)
Last updated
Summary
Product
Claritin® Rapid Dissolve
Issue
Health products - Contamination
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Claritin® Rapid Dissolve | Claritin® Rapid Dissolve | DIN 02237734 | Tablet (Orally Disintegrating) | Loratadine 10 mg | 10-pack blister: - 5147777 - 5394252A 30-pack blister: - 5147777A - 5147776 - 5147776B - 5147774 - 5197727 - 5197727A - 5197725 - 5197660 50-pack blister: - 5147776A - 5055251 - 5055251A - 5055246 - 5394248 |
Issue
Affected lots recalled due to potential contamination with asenapine and cedar pollen.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Bayer Inc.
2920 Matheson Blvd. E.,
Mississauga, Ontario
L4W 5R6
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-74773
Get notified
Receive emails about new and updated recall and safety alerts.